Rentschler Biopharma News and Activities

Rentschler Biopharma has a direct presence in 2 countries.

View the org chart displaying its 34 main executives

Most searched biographies at Rentschler Biopharma

• Torsten Woehr, Chief Executive Officer (starts on Aug 1 2026)
• Uwe Bücheler, Vice Chairman of the Board
• Carol Von Gersdorff, Director

Popular executive movements at Rentschler Biopharma

• Torsten Woehr will join the company as Chief Executive Officer on Aug. 1, 2026  (posted on July 3 2026).
• Uwe Bücheler who is Interim Chief Executive Officer, will become Vice Chairman of the Board on Aug. 1, 2026  (posted on July 3 2026).
• Veit Bergendahl will join the company as Chief Operating Officer on Apr. 1, 2026  (posted on February 17 2026).

Click here to view some more movements at Rentschler Biopharma

Create your alert
to follow the executive moves at Rentschler Biopharma.

Rentschler Biopharma has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Rentschler Biopharma

• Rentschler Biopharma ernennt Dr. Torsten Wöhr zum Chief Executive Officer
• Together We Build: Rentschler Biopharma blickt auf erfolgreiches Wachstum und positive Standortentwicklung in Milford seit der US-Expansion
• Rentschler Biopharma beruft Dr. Veit Bergendahl zum Chief Operating Officer und in den Vorstand
• Rentschler Biopharma kündigt Veränderungen in der Geschäftsführung und nächste Phase der Unternehmensstrategie an
• Rentschler Biopharma ernennt Detra Glinatsis zum Head of Business Development U.S.
• VarmX und Rentschler Biopharma kooperieren, um neuartige Gerinnungstherapie in Phase 3 und zur Kommerzialisierung voranzubringen
• Rentschler Biopharma Inc. gewinnt "Manufacturer of the Year"Preis für Zentral-Massachusetts
• Rentschler Biopharma und Coriolis Pharma geben strategische Zusammenarbeit für integrierte Biopharma-Lösungen bekannt
• Together We Build: Rentschler Biopharma feiert Baufortschritt der größten Einzelinvestition am Standort Laupheim
• Rentschler Biopharma erweitert seine Dienstleistungen in Japan und Südkorea weiter und wird an der BioProcess International Asia teilnehmen
• View more press releases Close

Social media about Rentschler Biopharma

• Rentschler Biopharma on Wikipedia, Google News & Yahoo Finance
• Rentschler Biopharma on LinkedIn, X (Twitter) & YouTube